Stay updated on Emricasan in NASH Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.

Latest updates to the Emricasan in NASH Fibrosis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label on the page updated from v3.6.4 to v3.6.5. This signifies a minor build/content update and does not change the study information presented.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedFooter revision label updated from v3.6.3 to v3.6.4, indicating a small update to the page's versioning. It does not modify any study data or displayed content.SummaryDifference0.0%

- Check41 days agoChange DetectedSteatotic Liver Disease has been added and Fatty Liver Disease removed from the page's keyword taxonomy, reflecting updated naming conventions for liver conditions and affecting how the study is indexed and discovered.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page now shows Revision: v3.6.3 instead of v3.6.2, signaling a small underlying update to the site version rather than a modification to study details.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a new revision in the page history.SummaryDifference0.0%

- Check70 days agoChange DetectedThe study page now shows recruitment status 'No longer looking for participants', indicating enrollment is closed. It also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading while removing the older revision label.SummaryDifference0.2%

Stay in the know with updates to Emricasan in NASH Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emricasan in NASH Fibrosis Clinical Trial page.